pillbase.ru

Vizimpro

Active substance: dacomitinib

TABLET, FILM COATED · DACOMITINIB 30 mg/1

United StatesActive

Marketing holder: Pfizer Laboratories Div Pfizer Inc

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 1
  • Vizimpro
    dacomitinib monohydrate
    EMEA/H/C/004779
    Pfizer Europe MA EEIG
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-f332-7404-aef2-6a7ab3d35930,01a12091-505e-7322-bf17-d45f8522bf0b,01a1209a-328f-7b72-97aa-f0a1d0d8a2fe;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
0069-1198
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 0069-1198 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 0069-1198 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 0069-1198 · Verified 2026-10-09 · open in source